Washington, D.C.
The U.S. Department of Health and Human Services proposed a new strategic plan for public health emergency preparedness in August of 2010. Designed to optimize vaccine creation and supply, the plan includes a significant investment in the Food and Drug Administration to streamline the process by which vaccines are reviewed and approved. Centers of Innovation for Advanced Development and Manufacturing would be established, and flu vaccine manufacturing would be upgraded. A strategic investment fund would be created to help smaller companies attract investors, and companies would be assisted in getting therapeutics through clinical trials to distribution.
